Distribution and drug resistance of 433 clinical acinetobacter strains
Lan Liu
Abstract
Lan Liu
Abstract
Objective:To investigate the distribution and drug resistance of clinical acinetobacter strains in our hospital.Methods: Drug resistance of acinetobacter strains from Jan.2008 to Dec.2008 were analyzed.The strains were identified and drug susceptibility was tested by BD Phoenix automated microbiology system.Results:360 strains were isolated from sputum.32.6% acinetobacter strains were from respiratory department,followed by the intensive care unit and the neonatal department(12.9%).The drug resistance of acinetobacter baumannii to colistin,impenem,meropenem was 0.78%,6.01% and 1.57% respectively.Acinetobacter lwoffi was more sensitive to some antimicrobial agents than Acinetobacter baumannii.Conclusion:Clinical acinetobacter mainly comes from the sputum and respiratory department.The resistant rate is high.We should enhance the surveillance of antimicrobial resistance and choose proper antimicrobial agents.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the distribution and drug resistance of clinical acinetobacter strains in our hospital.Methods: Drug resistance of acinetobacter strains from Jan.2008 to Dec.2008 were analyzed.The strains were identified and drug susceptibility was tested by BD Phoenix automated microbiology system.Results:360 strains were isolated from sputum.32.6% acinetobacter strains were from respiratory department,followed by the intensive care unit and the neonatal department(12.9%).The drug resistance of acinetobacter baumannii to colistin,impenem,meropenem was 0.78%,6.01% and 1.57% respectively.Acinetobacter lwoffi was more sensitive to some antimicrobial agents than Acinetobacter baumannii.Conclusion:Clinical acinetobacter mainly comes from the sputum and respiratory department.The resistant rate is high.We should enhance the surveillance of antimicrobial resistance and choose proper antimicrobial agents.
Key concepts: Acinetobacter baumannii, Medicine, Acinetobacter, Microbiology, Drug resistance, Meropenem, Colistin, Antimicrobial